Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
Allyson Whyte Nowak
ID:
1b839958-2619-30fb-68c4
/
Claimed Record
/
Organization:
Norton Rose Fulbright
Published Works
35 articles
Federal Court reinstates damages decision concerning prejudgment interest
Pharma in Brief ·
January 15, 2020
cite
Ontario reduces restrictions on ordinary commercial term benefits and private label products
Pharma in Brief ·
December 17, 2019
cite
FCA Confirms Entirety of Inventors’ Conduct is Relevant in Obviousness Analysis and Upholds Inventiveness of Crystal Form Patent
Pharma in Brief ·
February 14, 2019
cite
FCA Confirms that Non-Infringing Alternative Must be Legal and Objectively Economically Viable
Pharma in Brief ·
December 20, 2018
cite
ONCA Permits Pleading Amendments Asserting Validity of Previously Invalidated Patent following Nexium Decision
Pharma in Brief ·
November 18, 2018
cite
Previous
1
2
3
4
5
6
7
Next
Practice Areas
Health Care and Life Sciences
Intellectual Property
Jurisdictions
Canada
North America
United States
